<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03895307</url>
  </required_header>
  <id_info>
    <org_study_id>ademerbirol</org_study_id>
    <nct_id>NCT03895307</nct_id>
  </id_info>
  <brief_title>Comparison of Kinesio Taping and Local Injection in Chronic Low Back Pain</brief_title>
  <official_title>Comparison of Kinesio Taping and Local Injection in Chronic Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Low back pain can be seen in every period of life. More than 80 percent of the society
      complain of low back pain at any time of life. Although the frequency of applying to a health
      institution due to low back pain varies from one society to the other, it takes place in the
      first three places in each community. Low back pain should be differentiated as new (acute)
      and long-term (chronic). In the treatment of chronic low back pain, rest, education,
      pharmacological treatment, physical therapy, painful point injections, surgical
      interventions, kinesio taping can be applied. The most frequently used physical therapy
      modalities for treatment of chronic low back pain are superficial and deep heat modalities
      (hot pack, infrared, ultrasound, microwave diathermy radar) and analgesic effective
      electrotherapy (TENS, interferential flows) modalities. One of the most important treatments
      is exercise therapy. In cases where conventional treatment of chronic low back pain is
      insufficient, that is, the patient's pain is still ongoing and functional recovery is
      insufficient, some alternative methods are also applied. These treatments include ozone,
      prolotherapy injection applications, dry needling, acupuncture, phytotherapy, balneotherapy,
      kinesio taping and so on. The aim of this study is to compare the efficacy of painful point
      injection and kinesio taping treatments in lumbar region in patients with chronic low back
      pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 84 volunteer patients will be included in the study, patients older than 18
      years, under 75 years of age, with a minimum of 3 months of mechanical back pain, Visual
      Analog Scale score of at least 60 patients will be included. Who are older than 18 years of
      age, having mental problems, having peripheral problems affecting the central nervous system,
      having received physical therapy to the lumbar region in the last 3 months, having been
      applied to the lumbar region within the last 3 months, having a history of lumbar region
      surgery, having a history of patients with motor deficit in the extremity, needle phobia,
      lidocaine and / or kinesio tape allergy, patients with wound, infection, burn, allergic
      lesions in the application area will not be included.

      Patients included in the study will be included in the first (first), second (second), third
      (third) or fourth (fourth) treatment group by random number generator method.

      The first group will be given the hot package (20 minutes / day) + exercise + 1. 4. 7. 10.
      13. 16. days.

      The second group will be given a hot package (20 minutes / day) + exercise + 1. 4. 7. 10. 13.
      16 days.

      The third group hot package (20 minutes / day) + exercise + 1. 4. 7. 10. 13. 16. days,
      kinesio tape will be applied to the determined areas.

      the fourth group hot package (20 minutes / day) + exercise + 1. 4. 7. 10. 13. 16. days sham
      tape application will be made in the regions determined. ****

        -  Patients in all groups will continue to use the hotpack and exercises until the 3rd
           month after the first day of their study. First session exercises with the same
           physiotherapist (stretching for back-waist, iliopsoas and hamstring muscles; exercise
           range of hip and waist; hip and waist isometric exercises). Each patient will do the
           exercises 20 minutes after the hot package application.

             -  saline and local anesthetic injection points to be applied to the lumbar region:

                  1. Future points on spinous projections from L1 to L5

                  2. Lumbar region 2 from the middle point of the spinous output bilateral and 2 cm
                     to 4 cm lateral points

                  3. To each point of the iliac lobe of iliac crest will be injected subcutaneously
                     with 0.5 ml 0.5% lidocaine-containing local anesthetic.

                  4. 6 mm 30 gauge needle tip will be used for injection.

                  5. For each patient who underwent subcutaneous local anesthetic, an average of
                     18-20 ml of 0.5% lidocaine-containing local anesthetic and 18-20 ml of 0.09%
                     NaCl-containing isotonic saline will be used for each patient.

                  6. These points are the points of quadle technique applied in neural therapy.

                       -  Kinesio taping will use 2 cut-to-length I-bands with a length of about 15
                          cm long for one patient. Space correction technique will be used for
                          patients. The lumbar region of the patients will be glued vertically to
                          the paravertebral muscles vertically 3-4 cm lateral to the spinous
                          projections. As a starting point for patients, S1 will be adhered to the
                          vertebra without tension, then the patient will be asked to come with
                          maximum lumbar flexion posterior.

                            -  For a patient in the treatment of sham kinesio taping, 2 pieces of
                               approximately 15 cm long ends will be used to cut the curved I
                               bands. The lumbar region of the patients will be glued vertically to
                               the paravertebral muscles vertically 3-4 cm lateral to the spinous
                               projections. Patients in the upright posture, kinesio tape S1
                               applied from the vertebra without stretching will be glued upwards
                               and taped upwards.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2, 2019</start_date>
  <completion_date type="Actual">August 1, 2019</completion_date>
  <primary_completion_date type="Actual">July 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Severity: Visual Analog Scale</measure>
    <time_frame>day 0 (before intervention)</time_frame>
    <description>visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Severity: Visual Analog Scale</measure>
    <time_frame>day 16 (after 6th application)</time_frame>
    <description>visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Severity: Visual Analog Scale</measure>
    <time_frame>1 month after intervention</time_frame>
    <description>visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Severity: Visual Analog Scale</measure>
    <time_frame>3 months after intervention</time_frame>
    <description>visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disability Severity: Oswestry Disabiliy Index</measure>
    <time_frame>day 0 (before intervention)</time_frame>
    <description>Oswestry Disabiliy Index:
minimum score: 0 maximum score: 50. Higher scores reflect more severe disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disability Severity: Oswestry Disability Index</measure>
    <time_frame>day 16 (after 6th application)</time_frame>
    <description>Oswestry Disabiliy Index:
minimum score: 0 maximum score: 50. Higher scores reflect more severe disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disability Severity: Oswestry Disability Index</measure>
    <time_frame>1 month after intervention</time_frame>
    <description>Oswestry Disabiliy Index:
minimum score: 0 maximum score: 50. Higher scores reflect more severe disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disability Severity: Oswestry Disability Index</measure>
    <time_frame>3 months after intervention</time_frame>
    <description>Oswestry Disabiliy Index:
minimum score: 0 maximum score: 50. Higher scores reflect more severe disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Quality of Life: Short Form 36 Physical Functioning</measure>
    <time_frame>day 0 (before intervention)</time_frame>
    <description>short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Quality of Life: Short Form 36 Physical Functioning</measure>
    <time_frame>day 16 (after 6th application)</time_frame>
    <description>short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Quality of Life: Short Form 36 Physical Functioning</measure>
    <time_frame>1 month after intervention</time_frame>
    <description>short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Quality of Life: Short Form 36 Physical Functioning</measure>
    <time_frame>3 months after intervention</time_frame>
    <description>short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spinal Mobility: Schober Test</measure>
    <time_frame>day 0 (before intervention)</time_frame>
    <description>Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion).
Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back.
A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed.
The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion.
Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spinal Mobility: Schober Test</measure>
    <time_frame>day 16 (after 6th application)</time_frame>
    <description>Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion).
Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back.
A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed.
The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion.
Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spinal Mobility: Schober Test</measure>
    <time_frame>1 month after intervention</time_frame>
    <description>Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion).
Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back.
A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed.
The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion.
Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spinal Mobility: Schober Test</measure>
    <time_frame>3 months after intervention</time_frame>
    <description>Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion).
Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back.
A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed.
The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion.
Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Quality of Life: Short Form-36 Mental Health</measure>
    <time_frame>day 0 before intervention</time_frame>
    <description>Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Quality of Life: Short Form-36 Mental Health</measure>
    <time_frame>day 16 (after 6th application)</time_frame>
    <description>Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Quality of Life: Short Form-36 Mental Health</measure>
    <time_frame>1 month after intervention</time_frame>
    <description>Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Quality of Life: Short Form-36 Mental Health</measure>
    <time_frame>3 months after intervention</time_frame>
    <description>Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Chronic Low Back Pain</condition>
  <arm_group>
    <arm_group_label>kinesio taping</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>two 15 cm I type kinesio tape applied longitudinally</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham kinesio taping</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>two 15 cm I type kinesio tape applied longitudinally but without stretching</description>
  </arm_group>
  <arm_group>
    <arm_group_label>local anesthetic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>18-20 cc %0.5 lidocaine subcutaneous injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>local serum physiologic</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>18-20 cc % 0.09 NaCl subcutaneous injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>kinesio tape</intervention_name>
    <description>two 15 cm I type kinesio tape applied longitudinally</description>
    <arm_group_label>kinesio taping</arm_group_label>
    <arm_group_label>sham kinesio taping</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>local anesthetic</intervention_name>
    <description>local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
    <arm_group_label>local anesthetic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>local serum physiologic</intervention_name>
    <description>serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
    <arm_group_label>local serum physiologic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Under 18 years of age under 75 years

          2. Chronic mechanic (decreased with resting and resting) for at least 3 months

          3. Visual Analogue Scale score of at least 60-

        Exclusion Criteria:

          1. Having mental problems

          2. Having the disease affecting the peripheral and central nervous system

          3. Have received physical therapy in the lumbar region within the last 3 months

          4. Injection into the lumbar region within the last 3 months

          5. Having a history of waist region surgery

          6. Low motor dysfunction in lower extremity in physical examination

          7. Needle phobia

          8. Is allergic to lidocaine

          9. Kinesio tape allergy

         10. Wound, infection, burn, allergic lesions in the application area
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ADEM ERBİROL</last_name>
    <role>Study Director</role>
    <affiliation>sultan abdulhamid han</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sultan 2.Abdülhamid Han Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <state>Eyalet/Yerleşke</state>
        <zip>34000</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sultan Abdülhamid Han Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <state>Eyalet/Yerleşke</state>
        <zip>34000</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>March 28, 2019</study_first_submitted>
  <study_first_submitted_qc>March 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2019</study_first_posted>
  <results_first_submitted>May 30, 2020</results_first_submitted>
  <results_first_submitted_qc>June 17, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">July 2, 2020</results_first_posted>
  <last_update_submitted>June 17, 2020</last_update_submitted>
  <last_update_submitted_qc>June 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic low back pain</keyword>
  <keyword>kinesio taping</keyword>
  <keyword>injection</keyword>
  <keyword>local anesthetic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>other researchers would get information from the main researcher. therefore it was not shared.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 1, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/07/NCT03895307/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Kinesio Taping</title>
          <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
        </group>
        <group group_id="P2">
          <title>Sham Kinesio Taping</title>
          <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
        </group>
        <group group_id="P3">
          <title>Local Anesthetic</title>
          <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
        </group>
        <group group_id="P4">
          <title>Local Serum Physiologic</title>
          <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="22"/>
                <participants group_id="P4" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
                <participants group_id="P4" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Kinesio Taping</title>
          <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
        </group>
        <group group_id="B2">
          <title>Sham Kinesio Taping</title>
          <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
        </group>
        <group group_id="B3">
          <title>Local Anesthetic</title>
          <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
        </group>
        <group group_id="B4">
          <title>Local Serum Physiologic</title>
          <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="22"/>
            <count group_id="B4" value="21"/>
            <count group_id="B5" value="84"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="74"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39.67" spread="15.72"/>
                    <measurement group_id="B2" value="47.20" spread="16.60"/>
                    <measurement group_id="B3" value="47.82" spread="15.95"/>
                    <measurement group_id="B4" value="41.48" spread="15.69"/>
                    <measurement group_id="B5" value="44.05" spread="16.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="12"/>
                    <measurement group_id="B5" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="21"/>
                    <measurement group_id="B5" value="84"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Turkey</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="21"/>
                    <measurement group_id="B5" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.63" spread="4.70"/>
                    <measurement group_id="B2" value="27.25" spread="3.88"/>
                    <measurement group_id="B3" value="27.05" spread="4.47"/>
                    <measurement group_id="B4" value="27.05" spread="3.73"/>
                    <measurement group_id="B5" value="27.24" spread="4.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Severity: Visual Analog Scale</title>
        <description>visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain</description>
        <time_frame>day 0 (before intervention)</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Severity: Visual Analog Scale</title>
          <description>visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.26" spread="0.8"/>
                    <measurement group_id="O2" value="7.75" spread="0.44"/>
                    <measurement group_id="O3" value="7.8" spread="0.89"/>
                    <measurement group_id="O4" value="7.62" spread="0.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain Severity: Visual Analog Scale</title>
        <description>visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain</description>
        <time_frame>day 16 (after 6th application)</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Severity: Visual Analog Scale</title>
          <description>visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.89" spread="2.1"/>
                    <measurement group_id="O2" value="3.35" spread="2.11"/>
                    <measurement group_id="O3" value="2.85" spread="1.98"/>
                    <measurement group_id="O4" value="3.52" spread="2.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain Severity: Visual Analog Scale</title>
        <description>visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain</description>
        <time_frame>1 month after intervention</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Severity: Visual Analog Scale</title>
          <description>visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.58" spread="2.56"/>
                    <measurement group_id="O2" value="4.65" spread="2.99"/>
                    <measurement group_id="O3" value="3.65" spread="2.36"/>
                    <measurement group_id="O4" value="5.81" spread="2.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain Severity: Visual Analog Scale</title>
        <description>visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain</description>
        <time_frame>3 months after intervention</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Severity: Visual Analog Scale</title>
          <description>visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.42" spread="2.41"/>
                    <measurement group_id="O2" value="5.20" spread="2.94"/>
                    <measurement group_id="O3" value="5" spread="2.77"/>
                    <measurement group_id="O4" value="6.48" spread="2.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Disability Severity: Oswestry Disabiliy Index</title>
        <description>Oswestry Disabiliy Index:
minimum score: 0 maximum score: 50. Higher scores reflect more severe disability</description>
        <time_frame>day 0 (before intervention)</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Disability Severity: Oswestry Disabiliy Index</title>
          <description>Oswestry Disabiliy Index:
minimum score: 0 maximum score: 50. Higher scores reflect more severe disability</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.42" spread="2.65"/>
                    <measurement group_id="O2" value="18.30" spread="3.45"/>
                    <measurement group_id="O3" value="17.1" spread="2.38"/>
                    <measurement group_id="O4" value="17.57" spread="1.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Disability Severity: Oswestry Disability Index</title>
        <description>Oswestry Disabiliy Index:
minimum score: 0 maximum score: 50. Higher scores reflect more severe disability</description>
        <time_frame>day 16 (after 6th application)</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Disability Severity: Oswestry Disability Index</title>
          <description>Oswestry Disabiliy Index:
minimum score: 0 maximum score: 50. Higher scores reflect more severe disability</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.68" spread="6.67"/>
                    <measurement group_id="O2" value="6.50" spread="6.66"/>
                    <measurement group_id="O3" value="6.15" spread="4.95"/>
                    <measurement group_id="O4" value="10.43" spread="5.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Disability Severity: Oswestry Disability Index</title>
        <description>Oswestry Disabiliy Index:
minimum score: 0 maximum score: 50. Higher scores reflect more severe disability</description>
        <time_frame>1 month after intervention</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Disability Severity: Oswestry Disability Index</title>
          <description>Oswestry Disabiliy Index:
minimum score: 0 maximum score: 50. Higher scores reflect more severe disability</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.84" spread="8.21"/>
                    <measurement group_id="O2" value="10.50" spread="7.58"/>
                    <measurement group_id="O3" value="8.85" spread="6.67"/>
                    <measurement group_id="O4" value="14.38" spread="4.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Disability Severity: Oswestry Disability Index</title>
        <description>Oswestry Disabiliy Index:
minimum score: 0 maximum score: 50. Higher scores reflect more severe disability</description>
        <time_frame>3 months after intervention</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Disability Severity: Oswestry Disability Index</title>
          <description>Oswestry Disabiliy Index:
minimum score: 0 maximum score: 50. Higher scores reflect more severe disability</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.84" spread="6.44"/>
                    <measurement group_id="O2" value="14.20" spread="6.52"/>
                    <measurement group_id="O3" value="13.35" spread="4.35"/>
                    <measurement group_id="O4" value="16.10" spread="3.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Quality of Life: Short Form 36 Physical Functioning</title>
        <description>short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life</description>
        <time_frame>day 0 (before intervention)</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Quality of Life: Short Form 36 Physical Functioning</title>
          <description>short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.1" spread="13.08"/>
                    <measurement group_id="O2" value="50.75" spread="14.53"/>
                    <measurement group_id="O3" value="45.9" spread="12.54"/>
                    <measurement group_id="O4" value="50.71" spread="12.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Quality of Life: Short Form 36 Physical Functioning</title>
        <description>short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life</description>
        <time_frame>day 16 (after 6th application)</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Quality of Life: Short Form 36 Physical Functioning</title>
          <description>short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.63" spread="14.75"/>
                    <measurement group_id="O2" value="74" spread="13.53"/>
                    <measurement group_id="O3" value="75" spread="15.39"/>
                    <measurement group_id="O4" value="74.05" spread="15.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Quality of Life: Short Form 36 Physical Functioning</title>
        <description>short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life</description>
        <time_frame>1 month after intervention</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Quality of Life: Short Form 36 Physical Functioning</title>
          <description>short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.11" spread="16.69"/>
                    <measurement group_id="O2" value="61.70" spread="19.47"/>
                    <measurement group_id="O3" value="67.20" spread="16.26"/>
                    <measurement group_id="O4" value="57.86" spread="16.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Quality of Life: Short Form 36 Physical Functioning</title>
        <description>short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life</description>
        <time_frame>3 months after intervention</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Quality of Life: Short Form 36 Physical Functioning</title>
          <description>short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.84" spread="13.26"/>
                    <measurement group_id="O2" value="55.15" spread="15.35"/>
                    <measurement group_id="O3" value="56.65" spread="16.27"/>
                    <measurement group_id="O4" value="54.05" spread="14.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Spinal Mobility: Schober Test</title>
        <description>Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion).
Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back.
A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed.
The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion.
Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.</description>
        <time_frame>day 0 (before intervention)</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Spinal Mobility: Schober Test</title>
          <description>Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion).
Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back.
A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed.
The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion.
Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.</description>
          <population>intent to treat population(all participants)</population>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.09" spread="0.58"/>
                    <measurement group_id="O2" value="4.37" spread="0.77"/>
                    <measurement group_id="O3" value="3.75" spread="0.88"/>
                    <measurement group_id="O4" value="4.38" spread="0.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Spinal Mobility: Schober Test</title>
        <description>Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion).
Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back.
A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed.
The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion.
Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.</description>
        <time_frame>day 16 (after 6th application)</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Spinal Mobility: Schober Test</title>
          <description>Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion).
Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back.
A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed.
The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion.
Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.</description>
          <population>intent to treat population(all participants)</population>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.36" spread="0.43"/>
                    <measurement group_id="O2" value="4.37" spread="0.77"/>
                    <measurement group_id="O3" value="4.27" spread="0.63"/>
                    <measurement group_id="O4" value="4.59" spread="0.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Spinal Mobility: Schober Test</title>
        <description>Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion).
Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back.
A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed.
The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion.
Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.</description>
        <time_frame>1 month after intervention</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Spinal Mobility: Schober Test</title>
          <description>Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion).
Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back.
A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed.
The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion.
Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.</description>
          <population>intent to treat population(all participants)</population>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.36" spread="0.43"/>
                    <measurement group_id="O2" value="4.42" spread="0.74"/>
                    <measurement group_id="O3" value="4.27" spread="0.63"/>
                    <measurement group_id="O4" value="4.54" spread="0.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Spinal Mobility: Schober Test</title>
        <description>Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion).
Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back.
A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed.
The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion.
Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.</description>
        <time_frame>3 months after intervention</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Spinal Mobility: Schober Test</title>
          <description>Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion).
Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back.
A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed.
The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion.
Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.</description>
          <population>intent to treat population(all participants)</population>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.36" spread="0.43"/>
                    <measurement group_id="O2" value="4.42" spread="0.74"/>
                    <measurement group_id="O3" value="4.2" spread="0.61"/>
                    <measurement group_id="O4" value="4.54" spread="0.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Quality of Life: Short Form-36 Mental Health</title>
        <description>Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.</description>
        <time_frame>day 0 before intervention</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Quality of Life: Short Form-36 Mental Health</title>
          <description>Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68" spread="0"/>
                    <measurement group_id="O2" value="67.5" spread="2.23"/>
                    <measurement group_id="O3" value="68" spread="0"/>
                    <measurement group_id="O4" value="68" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Quality of Life: Short Form-36 Mental Health</title>
        <description>Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.</description>
        <time_frame>day 16 (after 6th application)</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Quality of Life: Short Form-36 Mental Health</title>
          <description>Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.79" spread="7.48"/>
                    <measurement group_id="O2" value="78.6" spread="5.51"/>
                    <measurement group_id="O3" value="78" spread="5.51"/>
                    <measurement group_id="O4" value="77.52" spread="2.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Quality of Life: Short Form-36 Mental Health</title>
        <description>Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.</description>
        <time_frame>1 month after intervention</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Quality of Life: Short Form-36 Mental Health</title>
          <description>Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.16" spread="9.29"/>
                    <measurement group_id="O2" value="73.10" spread="7.96"/>
                    <measurement group_id="O3" value="76.6" spread="7.05"/>
                    <measurement group_id="O4" value="71.81" spread="4.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Quality of Life: Short Form-36 Mental Health</title>
        <description>Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.</description>
        <time_frame>3 months after intervention</time_frame>
        <population>intent to treat population(all participants)</population>
        <group_list>
          <group group_id="O1">
            <title>Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O2">
            <title>Sham Kinesio Taping</title>
            <description>two 15 cm I type kinesio tape applied longitudinally but without stretching
kinesio tape: two 15 cm I type kinesio tape applied longitudinally</description>
          </group>
          <group group_id="O3">
            <title>Local Anesthetic</title>
            <description>18-20 cc %0.5 lidocaine subcutaneous injection
local anesthetic: local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection</description>
          </group>
          <group group_id="O4">
            <title>Local Serum Physiologic</title>
            <description>18-20 cc % 0.09 NaCl subcutaneous injection
local serum physiologic: serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Quality of Life: Short Form-36 Mental Health</title>
          <description>Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health.
Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.</description>
          <population>intent to treat population(all participants)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.42" spread="7.96"/>
                    <measurement group_id="O2" value="72.1" spread="7.90"/>
                    <measurement group_id="O3" value="73.60" spread="7.93"/>
                    <measurement group_id="O4" value="71.33" spread="4.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>adverse events were not monitored/assessed</time_frame>
      <desc>adverse events were not monitored/assessed</desc>
      <group_list>
        <group group_id="E1">
          <title>Kinesio Tape</title>
          <description>two 15 cm I type kinesio tape applied longitudinally</description>
        </group>
        <group group_id="E2">
          <title>Sham Kinesio Taping</title>
          <description>two 15 cm I type kinesio tape applied longitudinally but without stretching</description>
        </group>
        <group group_id="E3">
          <title>Local Anesthetic</title>
          <description>18-20 cc %0.5 lidocaine subcutaneous injection</description>
        </group>
        <group group_id="E4">
          <title>Local Serum Physiologic</title>
          <description>18-20 cc % 0.09 NaCl subcutaneous injection</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Adem Erbirol</name_or_title>
      <organization>SultanAbdulhamid</organization>
      <phone>+905426608788</phone>
      <email>aerbirol@hotmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

